Abstract:The aim: to investigate and analyze clinical parameters, laboratory biomarkers of lipid metabolism and endothelial dysfunction gene polymorphisms in early-onset and late-onset preeclampsia and to identify potential risk factor(s) for the development of early-onset preeclampsia. Materials and methods: a prospective case-control study included 133 women in the second half of pregnancy, including 46 with early-onset (EOP) and 87 with late-onset preeclampsia (LOP) and 34 conditionally healthy pregnant women with an uncomplicated obstetric history and no risk factors for preeclampsia. Concentrations of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides in blood plasma were determined. Genetic polymorphisms of endothelial dysfunction (192 Q→R PON-1, 677 C→ T MTHFR) were studied using allele-specific polymerase chain reaction. Results: Early-onset preeclampsia is associated with an increased relative risk: preterm delivery by 2.08 times (95 % CI 1.48-2.93), operative delivery by 2.2 times (95 % CI 1.46-3.33), early operative delivery by 2.9 times (95 % CI 1.5-5.5), fetal distress during delivery by 3.78 times (95 % CI 1.2-11.9), a low score on the Apgar scale on the 1st minute, less than 6 points, by 2.59 times (95 % CI 1.84-3.66), on the 5th minute – 5.04 times (95 % CI 1.41-18.11), Grade III prematurity – 13.24 times (95 % CI 3.14-55.78) compared to women with late-onset preeclampsia. The study found that overweight was more often observed in patients with EOP (34.8 %) than in those with normal pregnancy (15.9 %) (p=0.02; OR=2.8; 95 % CI 1.03-7.7), obesity (BMI > 30 kg/m2) was more often recorded in those with LOP (33.33 %) than in the control group (3 (6.8 %)) (p=0.02; OR=6.8; 95 % CI 1.9-23.9). Patients in both groups with preeclampsia showed signs of dyslipidemia, but its significance in the development of early-onset or late-onset preeclampsia has not been separately proven. The study found that the number of carriers of MTHFR 677 TT in the group with EOP prevailed over the indicator of C group where there were no carriers of the pathological homozygote 677TT (p<0.05, OR= 20.73 95 % CI 1.16-371.28), and the T allele in the EOP group occurs 1.78 times more often than in the LOP group (p<0.05, OR=2.22; 95 % CI 1.26-3.88) and 2.43 times more often than in the C group (P<0.05, or= 3.15; 95 % CI 1.54-6.45). Conclusions: Factors of early onset of PE include pre-pregnancy, overweight, first pregnancy, a history of preeclampsia, and carrier of the 677T allele of the MTHFR gene

Ri sk factors fo recurrent preeclampsia and i ts relation ot mta ernal and fo fspring outcome

[Risk Factors of Recurrent Preeclampsia and Its Relation to Maternal and Offspring Outcome].

Prevention for recurrent preeclampsia

Body mass index, lipid profile, and endothelial dysfunction gene polymorphism in women with early-onset and late-onset preeclampsia

The Feto-Maternal Outcomes and Incidence of Early-and Late-Onset Preeclampsia

Pregnancy Outcome in Early versus Late Onset Preeclampsia

Clinical features of recurrent preeclampsia: a retrospective study of 109 recurrent preeclampsia patients

Clinical Analysis of Risk Factors and Perinatal Outcomes in Recurrent Pre-Eclampsia with Severe Features

The clinical features and prognostic analysis of early-onset preeclampsia

[Study on Clinical Risk of Maternal Underlying Medical Conditions and Onset of Preeclampsia].

Relationship among Potential Maternal Risk Factors, Prenatal Care and Characteristics of Preeclampsia

Analysis of postpartum hypertension in women with preeclampsia

[Clinical features and prognosis of early-onset preeclampsia].

Preeclampsia in Pregnant Women with Polycystic Ovary Syndrome: Risk Factor Analysis Based on a Retrospective Cohort Study.

Maternal and Perinatal Prognosis of Pregnancy with Chronic Hypertension and Analysis of Associated Factors

Retrospective analysis of perinatal outcomes of singleton pregnant women with early-onset severe preeclampsia superimposed on chronic hypertension

Comparing Maternal and Perinatal Outcomes in Pregnancies Complicated by Preeclampsia Superimposed Chronic Hypertension and Preeclampsia Alone

Analyzing clinical features and forecasting pregnancy outcomes of early-onset severe preeclampsia

Development, Validation, and Clinical Utility of a Risk Prediction Model for Recurrent Preeclampsia.

[Multivariate Analysis of Risk Factors with Placental Abruption in Preeclampsia].

A Follow-Up Study of Women with a History of Severe Preeclampsia: Relationship Between Metabolic Syndrome and Preeclampsia.